0001096906-24-000504.txt : 20240319 0001096906-24-000504.hdr.sgml : 20240319 20240319112005 ACCESSION NUMBER: 0001096906-24-000504 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001394319 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 342037594 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88629 FILM NUMBER: 24761508 BUSINESS ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 BUSINESS PHONE: 858-550-0780 MAIL ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc DATE OF NAME CHANGE: 20070324 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: aaronson wayne CENTRAL INDEX KEY: 0001925985 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 1011 FRESNO AVE CITY: BERKELEY STATE: CA ZIP: 94707 SC 13G/A 1 tcon_sc13ga.htm TRACON PHARMACEUTICALS, INC, SCH 13G/A

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 2)

 

Tracon Pharmaceuticals, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

89237H209

(CUSIP Number)

 

January 12, 2024

(Date of Event which requires filing of)

 

Check the appropriate box to designate the rule pursuant to which this Schedule this is filed.

 

 

¨

Rule 13d-1(b)

 

x

Rule 13d-1(c)

 

¨

Rule 13d-1(d)


 

  SCHEDULE 13G

 

CUSIP NO. 89237H209

Page 2 of 4

 

1

NAMES OF REPORTING PERSONS

 

WAYNE AARONSON

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3

SEC USE ONLY

 

4

CITIZENSHIP

 

UNITED STATES



NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

 

716,925 shares

6

SHARED VOTING POWER

 

no shares

7

SOLE DISPOSITIVE POWER

 

716,925 shares

8

SHARED DISPOSITIVE POWER

 

no shares

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

716,925

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

N/A

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

2.3%

12

TYPE OF REPORTING PERSON

 

Individual


 

CUSIP NO. 89237H209

Page 3 of 4

 

Item 1.

 

 

 

 

(a)

Name of Issuer:

 

 

 

 

 

Tracon Pharmaceuticals, Inc.

 

 

 

 

(b)

Address of Issuer’s Principal Executive Offices:

 

 

 

 

 

4350 La Jolla Village Drive, Suite 800

 

 

San Diego, CA 92122

 

Item 2.

 

 

 

 

(a)

Name of Person Filing:

 

 

 

 

 

WAYNE AARONSON

 

 

 

 

(b)

Address of Principal Business Office or, if none, Residence

 

 

 

 

 

1011 Fresno Ave.

 

 

Berkeley, CA 94707

 

 

 

 

(c)

Citizenship:

 

 

 

 

 

United States

 

 

 

 

(d)

Title of Class of Securities

 

 

 

 

 

Common Stock

 

 

 

 

(e)

CUSIP Number

 

 

 

 

 

89237H209

 

Item 3.

 

N/A


 

CUSIP NO. 89237H209

Page 4 of 4

 

Item 4.

Ownership.

 

(a)716,945 shares of common stock held by Wayne Aaronson  

 

Roth IRA and no common stock held by Aaronson

 

Revocable Trust, Wayne Aaronson and Joy Chiyo Goto

 

co-trustees.

 

 

b)Percent of class: 2.3% based on 31,144,335 shares of Common Stock outstanding as of November 9, 2023 per Tracon's 10-K. 0 Number of shares as to which the person has:
 

(i)Sole power to vote or to direct the vote: 716,925 

 

(ii)Shared power to vote or to direct the vote: 0 

 

(iii)Sole power to dispose or to direct the disposition of: 716.925 

 

(iv)Shared power to dispose or to direct the disposition of: 0 

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

XX 

 

Item 6.

Ownership of More than Five percent on Behalf of Another Person:

 

n/a

 

Item 8.

ID of Members of the Group:.

 

n/a

 

Item 9.

Notice of Dissolution of Group.

 

n/a

 

Item 10.

Certifications.

 

n/a After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct: 

 

March 15, 2023

 

By:

/s/Wayne Aaronson

 

 

Wayne Aaronson